Increased risk of cardiovascular disease with erythropoietin in chronic dialysis patients
العنوان: | Increased risk of cardiovascular disease with erythropoietin in chronic dialysis patients |
---|---|
المؤلفون: | Teruo Kowatari, Shigeharu Terukina, Koshiro Fukiyama, Kunitoshi Iseki, Shigeki Toma, Kunio Yoshihara, Hajime Uehara, Keizo Nishime, Akira Osawa, Kiyoyuki Tokuyama |
المصدر: | Nephron. 72(1) |
سنة النشر: | 1996 |
مصطلحات موضوعية: | Male, medicine.medical_specialty, medicine.medical_treatment, Population, Myocardial Infarction, Japan, Renal Dialysis, Risk Factors, Internal medicine, medicine, Diabetes Mellitus, Humans, Myocardial infarction, Risk factor, education, Stroke, Erythropoietin, Dialysis, education.field_of_study, business.industry, Incidence (epidemiology), Odds ratio, Middle Aged, medicine.disease, Kidney Transplantation, Surgery, Cerebrovascular Disorders, Cardiovascular Diseases, Kidney Failure, Chronic, Female, business, medicine.drug |
الوصف: | Recombinant human erythropoietin is widely used in chronic dialysis patients. However, the long-term effect, especially on the incidence of cardiovascular disease, has not been critically evaluated. We observed the annual incidence of stroke and acute myocardial infarction from April 1988 through March 1993 in Okinawa, Japan. Until April 1990, erythropoietin was not generally used. Therefore, we have two periods: pre-erythropoietin, April 1988 through March 1990, and post-erythropoietin, April 1990 through March 1993. Two thousand one hundred and sixteen patients (1,219 males and 897 females) were on chronic dialysis during the study period by March 31, 1993. Every case of stroke and acute myocardial infarction during the study period was registered. The odds ratio was calculated using the data of the general population in each sex and age class obtained in the same area. A total of 86 cases of stroke and 15 cases of acute myocardial infarction were registered during the study period. The annual incidence, per 1,000 patient-years, of stroke was 12.5 (1988), 10.5 (1989), 12.7 (1990), 14.0 (1991), and 17.5 (1992). The incidence of stroke was increased in the post-erythropoietin period compared to the pre-erythropoietin period, odds ratio 1.22 and 95% confidence interval (95% CI 1.06-1.41, p < 0.01). The annual incidence of acute myocardial infarction was 1.0 (1988), 1.8 (1989), 0.8 (1990), 2.9 (1991) and 4.7 (1992). The incidence of acute myocardial infarction was increased significantly in the post-erythropoietin period compared to the pre-erythropoietin period, odds ratio 1.87 (95% CI 1.66-2.10, p < 0.01). The odds ratio of stroke to the general population was 4.25 (95% CI 3.10-5.82) in the pre-erythropoietin and 4.58 (95% CI 2.14-9.80) in the post-erythropoietin period. In acute myocardial infarction, it was 2.98 (95% CI 2.84-3.12) and 3.81 (95% CI 3.18-4.56). The odds ratio of acute myocardial infarction was significantly increased (p < 0.01). The introduction of erythropoietin was associated with an increased risk of cardiovascular disease, especially acute myocardial infarction. Erythropoietin may unmask the sclerotic lesion in chronic dialysis patients. |
تدمد: | 1660-8151 |
URL الوصول: | https://explore.openaire.eu/search/publication?articleId=doi_dedup___::94a82045ae95cc5c5229d69e913ce796 https://pubmed.ncbi.nlm.nih.gov/9171310 |
Rights: | CLOSED |
رقم الانضمام: | edsair.doi.dedup.....94a82045ae95cc5c5229d69e913ce796 |
قاعدة البيانات: | OpenAIRE |
ResultId |
1 |
---|---|
Header |
edsair OpenAIRE edsair.doi.dedup.....94a82045ae95cc5c5229d69e913ce796 748 3 unknown 748.129577636719 |
PLink |
https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....94a82045ae95cc5c5229d69e913ce796&custid=s6537998&authtype=sso |
FullText |
Array
(
[Availability] => 0
)
Array ( [0] => Array ( [Url] => https://explore.openaire.eu/search/publication?articleId=doi_dedup___::94a82045ae95cc5c5229d69e913ce796# [Name] => EDS - OpenAIRE [Category] => fullText [Text] => View record in OpenAIRE [MouseOverText] => View record in OpenAIRE ) ) |
Items |
Array
(
[Name] => Title
[Label] => Title
[Group] => Ti
[Data] => Increased risk of cardiovascular disease with erythropoietin in chronic dialysis patients
)
Array ( [Name] => Author [Label] => Authors [Group] => Au [Data] => <searchLink fieldCode="AR" term="%22Teruo+Kowatari%22">Teruo Kowatari</searchLink><br /><searchLink fieldCode="AR" term="%22Shigeharu+Terukina%22">Shigeharu Terukina</searchLink><br /><searchLink fieldCode="AR" term="%22Koshiro+Fukiyama%22">Koshiro Fukiyama</searchLink><br /><searchLink fieldCode="AR" term="%22Kunitoshi+Iseki%22">Kunitoshi Iseki</searchLink><br /><searchLink fieldCode="AR" term="%22Shigeki+Toma%22">Shigeki Toma</searchLink><br /><searchLink fieldCode="AR" term="%22Kunio+Yoshihara%22">Kunio Yoshihara</searchLink><br /><searchLink fieldCode="AR" term="%22Hajime+Uehara%22">Hajime Uehara</searchLink><br /><searchLink fieldCode="AR" term="%22Keizo+Nishime%22">Keizo Nishime</searchLink><br /><searchLink fieldCode="AR" term="%22Akira+Osawa%22">Akira Osawa</searchLink><br /><searchLink fieldCode="AR" term="%22Kiyoyuki+Tokuyama%22">Kiyoyuki Tokuyama</searchLink> ) Array ( [Name] => TitleSource [Label] => Source [Group] => Src [Data] => <i>Nephron</i>. 72(1) ) Array ( [Name] => DatePubCY [Label] => Publication Year [Group] => Date [Data] => 1996 ) Array ( [Name] => Subject [Label] => Subject Terms [Group] => Su [Data] => <searchLink fieldCode="DE" term="%22Male%22">Male</searchLink><br /><searchLink fieldCode="DE" term="%22medicine%2Emedical%5Fspecialty%22">medicine.medical_specialty</searchLink><br /><searchLink fieldCode="DE" term="%22medicine%2Emedical%5Ftreatment%22">medicine.medical_treatment</searchLink><br /><searchLink fieldCode="DE" term="%22Population%22">Population</searchLink><br /><searchLink fieldCode="DE" term="%22Myocardial+Infarction%22">Myocardial Infarction</searchLink><br /><searchLink fieldCode="DE" term="%22Japan%22">Japan</searchLink><br /><searchLink fieldCode="DE" term="%22Renal+Dialysis%22">Renal Dialysis</searchLink><br /><searchLink fieldCode="DE" term="%22Risk+Factors%22">Risk Factors</searchLink><br /><searchLink fieldCode="DE" term="%22Internal+medicine%22">Internal medicine</searchLink><br /><searchLink fieldCode="DE" term="%22medicine%22">medicine</searchLink><br /><searchLink fieldCode="DE" term="%22Diabetes+Mellitus%22">Diabetes Mellitus</searchLink><br /><searchLink fieldCode="DE" term="%22Humans%22">Humans</searchLink><br /><searchLink fieldCode="DE" term="%22Myocardial+infarction%22">Myocardial infarction</searchLink><br /><searchLink fieldCode="DE" term="%22Risk+factor%22">Risk factor</searchLink><br /><searchLink fieldCode="DE" term="%22education%22">education</searchLink><br /><searchLink fieldCode="DE" term="%22Stroke%22">Stroke</searchLink><br /><searchLink fieldCode="DE" term="%22Erythropoietin%22">Erythropoietin</searchLink><br /><searchLink fieldCode="DE" term="%22Dialysis%22">Dialysis</searchLink><br /><searchLink fieldCode="DE" term="%22education%2Efield%5Fof%5Fstudy%22">education.field_of_study</searchLink><br /><searchLink fieldCode="DE" term="%22business%2Eindustry%22">business.industry</searchLink><br /><searchLink fieldCode="DE" term="%22Incidence+%28epidemiology%29%22">Incidence (epidemiology)</searchLink><br /><searchLink fieldCode="DE" term="%22Odds+ratio%22">Odds ratio</searchLink><br /><searchLink fieldCode="DE" term="%22Middle+Aged%22">Middle Aged</searchLink><br /><searchLink fieldCode="DE" term="%22medicine%2Edisease%22">medicine.disease</searchLink><br /><searchLink fieldCode="DE" term="%22Kidney+Transplantation%22">Kidney Transplantation</searchLink><br /><searchLink fieldCode="DE" term="%22Surgery%22">Surgery</searchLink><br /><searchLink fieldCode="DE" term="%22Cerebrovascular+Disorders%22">Cerebrovascular Disorders</searchLink><br /><searchLink fieldCode="DE" term="%22Cardiovascular+Diseases%22">Cardiovascular Diseases</searchLink><br /><searchLink fieldCode="DE" term="%22Kidney+Failure%2C+Chronic%22">Kidney Failure, Chronic</searchLink><br /><searchLink fieldCode="DE" term="%22Female%22">Female</searchLink><br /><searchLink fieldCode="DE" term="%22business%22">business</searchLink><br /><searchLink fieldCode="DE" term="%22medicine%2Edrug%22">medicine.drug</searchLink> ) Array ( [Name] => Abstract [Label] => Description [Group] => Ab [Data] => Recombinant human erythropoietin is widely used in chronic dialysis patients. However, the long-term effect, especially on the incidence of cardiovascular disease, has not been critically evaluated. We observed the annual incidence of stroke and acute myocardial infarction from April 1988 through March 1993 in Okinawa, Japan. Until April 1990, erythropoietin was not generally used. Therefore, we have two periods: pre-erythropoietin, April 1988 through March 1990, and post-erythropoietin, April 1990 through March 1993. Two thousand one hundred and sixteen patients (1,219 males and 897 females) were on chronic dialysis during the study period by March 31, 1993. Every case of stroke and acute myocardial infarction during the study period was registered. The odds ratio was calculated using the data of the general population in each sex and age class obtained in the same area. A total of 86 cases of stroke and 15 cases of acute myocardial infarction were registered during the study period. The annual incidence, per 1,000 patient-years, of stroke was 12.5 (1988), 10.5 (1989), 12.7 (1990), 14.0 (1991), and 17.5 (1992). The incidence of stroke was increased in the post-erythropoietin period compared to the pre-erythropoietin period, odds ratio 1.22 and 95% confidence interval (95% CI 1.06-1.41, p < 0.01). The annual incidence of acute myocardial infarction was 1.0 (1988), 1.8 (1989), 0.8 (1990), 2.9 (1991) and 4.7 (1992). The incidence of acute myocardial infarction was increased significantly in the post-erythropoietin period compared to the pre-erythropoietin period, odds ratio 1.87 (95% CI 1.66-2.10, p < 0.01). The odds ratio of stroke to the general population was 4.25 (95% CI 3.10-5.82) in the pre-erythropoietin and 4.58 (95% CI 2.14-9.80) in the post-erythropoietin period. In acute myocardial infarction, it was 2.98 (95% CI 2.84-3.12) and 3.81 (95% CI 3.18-4.56). The odds ratio of acute myocardial infarction was significantly increased (p < 0.01). The introduction of erythropoietin was associated with an increased risk of cardiovascular disease, especially acute myocardial infarction. Erythropoietin may unmask the sclerotic lesion in chronic dialysis patients. ) Array ( [Name] => ISSN [Label] => ISSN [Group] => ISSN [Data] => 1660-8151 ) Array ( [Name] => URL [Label] => Access URL [Group] => URL [Data] => <link linkTarget="URL" linkTerm="https://explore.openaire.eu/search/publication?articleId=doi_dedup___::94a82045ae95cc5c5229d69e913ce796" linkWindow="_blank">https://explore.openaire.eu/search/publication?articleId=doi_dedup___::94a82045ae95cc5c5229d69e913ce796</link><br /><link linkTarget="URL" linkTerm="https://pubmed.ncbi.nlm.nih.gov/9171310" linkWindow="_blank">https://pubmed.ncbi.nlm.nih.gov/9171310</link> ) Array ( [Name] => Copyright [Label] => Rights [Group] => Cpyrght [Data] => CLOSED ) Array ( [Name] => AN [Label] => Accession Number [Group] => ID [Data] => edsair.doi.dedup.....94a82045ae95cc5c5229d69e913ce796 ) |
RecordInfo |
Array
(
[BibEntity] => Array
(
[Languages] => Array
(
[0] => Array
(
[Text] => Undetermined
)
)
[Subjects] => Array
(
[0] => Array
(
[SubjectFull] => Male
[Type] => general
)
[1] => Array
(
[SubjectFull] => medicine.medical_specialty
[Type] => general
)
[2] => Array
(
[SubjectFull] => medicine.medical_treatment
[Type] => general
)
[3] => Array
(
[SubjectFull] => Population
[Type] => general
)
[4] => Array
(
[SubjectFull] => Myocardial Infarction
[Type] => general
)
[5] => Array
(
[SubjectFull] => Japan
[Type] => general
)
[6] => Array
(
[SubjectFull] => Renal Dialysis
[Type] => general
)
[7] => Array
(
[SubjectFull] => Risk Factors
[Type] => general
)
[8] => Array
(
[SubjectFull] => Internal medicine
[Type] => general
)
[9] => Array
(
[SubjectFull] => medicine
[Type] => general
)
[10] => Array
(
[SubjectFull] => Diabetes Mellitus
[Type] => general
)
[11] => Array
(
[SubjectFull] => Humans
[Type] => general
)
[12] => Array
(
[SubjectFull] => Myocardial infarction
[Type] => general
)
[13] => Array
(
[SubjectFull] => Risk factor
[Type] => general
)
[14] => Array
(
[SubjectFull] => education
[Type] => general
)
[15] => Array
(
[SubjectFull] => Stroke
[Type] => general
)
[16] => Array
(
[SubjectFull] => Erythropoietin
[Type] => general
)
[17] => Array
(
[SubjectFull] => Dialysis
[Type] => general
)
[18] => Array
(
[SubjectFull] => education.field_of_study
[Type] => general
)
[19] => Array
(
[SubjectFull] => business.industry
[Type] => general
)
[20] => Array
(
[SubjectFull] => Incidence (epidemiology)
[Type] => general
)
[21] => Array
(
[SubjectFull] => Odds ratio
[Type] => general
)
[22] => Array
(
[SubjectFull] => Middle Aged
[Type] => general
)
[23] => Array
(
[SubjectFull] => medicine.disease
[Type] => general
)
[24] => Array
(
[SubjectFull] => Kidney Transplantation
[Type] => general
)
[25] => Array
(
[SubjectFull] => Surgery
[Type] => general
)
[26] => Array
(
[SubjectFull] => Cerebrovascular Disorders
[Type] => general
)
[27] => Array
(
[SubjectFull] => Cardiovascular Diseases
[Type] => general
)
[28] => Array
(
[SubjectFull] => Kidney Failure, Chronic
[Type] => general
)
[29] => Array
(
[SubjectFull] => Female
[Type] => general
)
[30] => Array
(
[SubjectFull] => business
[Type] => general
)
[31] => Array
(
[SubjectFull] => medicine.drug
[Type] => general
)
)
[Titles] => Array
(
[0] => Array
(
[TitleFull] => Increased risk of cardiovascular disease with erythropoietin in chronic dialysis patients
[Type] => main
)
)
)
[BibRelationships] => Array
(
[HasContributorRelationships] => Array
(
[0] => Array
(
[PersonEntity] => Array
(
[Name] => Array
(
[NameFull] => Teruo Kowatari
)
)
)
[1] => Array
(
[PersonEntity] => Array
(
[Name] => Array
(
[NameFull] => Shigeharu Terukina
)
)
)
[2] => Array
(
[PersonEntity] => Array
(
[Name] => Array
(
[NameFull] => Koshiro Fukiyama
)
)
)
[3] => Array
(
[PersonEntity] => Array
(
[Name] => Array
(
[NameFull] => Kunitoshi Iseki
)
)
)
[4] => Array
(
[PersonEntity] => Array
(
[Name] => Array
(
[NameFull] => Shigeki Toma
)
)
)
[5] => Array
(
[PersonEntity] => Array
(
[Name] => Array
(
[NameFull] => Kunio Yoshihara
)
)
)
[6] => Array
(
[PersonEntity] => Array
(
[Name] => Array
(
[NameFull] => Hajime Uehara
)
)
)
[7] => Array
(
[PersonEntity] => Array
(
[Name] => Array
(
[NameFull] => Keizo Nishime
)
)
)
[8] => Array
(
[PersonEntity] => Array
(
[Name] => Array
(
[NameFull] => Akira Osawa
)
)
)
[9] => Array
(
[PersonEntity] => Array
(
[Name] => Array
(
[NameFull] => Kiyoyuki Tokuyama
)
)
)
)
[IsPartOfRelationships] => Array
(
[0] => Array
(
[BibEntity] => Array
(
[Dates] => Array
(
[0] => Array
(
[D] => 01
[M] => 01
[Type] => published
[Y] => 1996
)
)
[Identifiers] => Array
(
[0] => Array
(
[Type] => issn-print
[Value] => 16608151
)
[1] => Array
(
[Type] => issn-locals
[Value] => edsair
)
)
[Numbering] => Array
(
[0] => Array
(
[Type] => volume
[Value] => 72
)
[1] => Array
(
[Type] => issue
[Value] => 1
)
)
[Titles] => Array
(
[0] => Array
(
[TitleFull] => Nephron
[Type] => main
)
)
)
)
)
)
)
|
IllustrationInfo |